Ruian Xu
- Cancer Research top 5%
- MicroRNA in disease regulation 4
- Genetics top 5%
- Virus-based gene therapy research 28
- Molecular Biology top 5%
- RNA Interference and Gene Delivery 15
- Viral Infectious Diseases and Gene Expression in Insects 6
- Natural product bioactivities and synthesis 4
- Hepatology top 5%
- Biotechnology top 5%
- Cancer Research and Treatments 6
-
- interferon and immune responses 4
-
- CAR-T cell therapy research 4
Ruian Xu
77 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 121
- Cancer Research 380
- Genetics 622
- Molecular Biology 1.4k
- Hepatology 122
- Biotechnology 104
Countries citing papers authored by Ruian Xu
This map shows the geographic impact of Ruian Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruian Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruian Xu more than expected).
Fields of papers citing papers by Ruian Xu
This network shows the impact of papers produced by Ruian Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruian Xu. The network helps show where Ruian Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ruian Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 11 | |
| 2 | 2021 | 7 | |
| 3 | 2021 | 11 | |
| 4 | 2019 | 12 | |
| 5 | The strategies of targeting therapy of hepatocellular carcinoma by adeno-associated virus | 2017 | 1 |
| 6 | 2016 | 8 | |
| 7 | 2011 | 16 | |
| 8 | 2010 | 54 | |
| 9 | 2010 | 42 | |
| 10 | Preparation,Purification and Activity of Recombinant Rat Cytoglobin | 2009 | 1 |
| 11 | 2009 | 21 | |
| 12 | 2009 | 60 | |
| 13 | 2008 | 51 | |
| 14 | 2008 | 14 | |
| 15 | Adeno-associated virus-mediated pancreatic and duodenal homeobox gene 1 delivery induced insulin-producing cells in livers of diabetic rats | 2007 | 1 |
| 16 | 2006 | 22 | |
| 17 | 2005 | 31 | |
| 18 | 2003 | 5 | |
| 19 | 2003 | 43 | |
| 20 | 1998 | 109 |
About Ruian Xu
Ruian Xu is a scholar working on Genetics, Biotechnology and Molecular Biology, having authored 80 papers that have together received 2.5k indexed citations. Recurring topics across this work include Virus-based gene therapy research (28 papers), RNA Interference and Gene Delivery (15 papers), Cancer Research and Treatments (6 papers), Viral Infectious Diseases and Gene Expression in Insects (6 papers), interferon and immune responses (4 papers), MicroRNA in disease regulation (4 papers), Natural product bioactivities and synthesis (4 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Cancer Research (380 citations), Genetics (622 citations) and Molecular Biology (1.4k citations). Ruian Xu has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Matthew J. During, Mingqing Tang, William Xu, Deborah Young, Dexian Zheng, Jun Lin, Helen L. Fitzsimons, Paola Leone, Zhenjing Zhuang and Farzin Farzaneh. Their work appears in journals such as Human Gene Therapy, International Journal of Cancer, Hepatology, Molecules and Marine Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.